EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Derivation and Characterization of Isogenic OPA1 Mutant and Control Human Pluripotent Stem Cell Lines

Katherine A Pohl, Xiangmei Zhang, Johnny Jeonghyun Ji, Linsey Stiles, Alfredo A Sadun, Xian-Jie Yang iD

Cells · 2025

DOI: 10.3390/cells14020137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Katherine A Pohl und 5 weiteren Autor:innen. Beteiligte Einrichtung: Jules Stein Eye Institute, Department of Ophthalmology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA. Hauptthemen laut MEDLINE: GTP Phosphohydrolases, Mutation, Optic Atrophy, Autosomal Dominant, Pluripotent Stem Cells. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIH HHS, National Institute of Health (NIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dominant optic atrophy (DOA) is the most commonly inherited optic neuropathy. The majority of DOA is caused by mutations in the OPA1 gene, which encodes a dynamin-related GTPase located to the mitochondrion. OPA1 has been shown to regulate mitochondrial dynamics and promote fusion. Within the mitochondrion, proteolytically processed OPA1 proteins form complexes to maintain membrane integrity and the respiratory chain complexity. Although OPA1 is broadly expressed, human OPA1 mutations predominantly affect retinal ganglion cells (RGCs) that are responsible for transmitting visual information from the retina to the brain. Due to the scarcity of human RGCs, DOA has not been studied in depth using the disease affected neurons. To enable studies of DOA using stem-cell-derived human RGCs, we performed CRISPR-Cas9 gene editing to generate OPA1 mutant pluripotent stem cell (PSC) lines with corresponding isogenic controls. CRISPR-Cas9 gene editing yielded both OPA1 homozygous and heterozygous mutant ESC lines from a parental control ESC line. In addition, CRISPR-mediated homology-directed repair (HDR) successfully corrected the OPA1 mutation in a DOA patient’s iPSCs. In comparison to the isogenic controls, the heterozygous mutant PSCs expressed the same OPA1 protein isoforms but at reduced levels; whereas the homozygous mutant PSCs showed a loss of OPA1 protein and altered mitochondrial morphology. Furthermore, OPA1 mutant PSCs exhibited reduced rates of oxygen consumption and ATP production associated with mitochondria. These isogenic PSC lines will be valuable tools for establishing OPA1-DOA disease models in vitro and developing treatments for mitochondrial deficiency associated neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GTP PhosphohydrolasesMutationOptic Atrophy, Autosomal DominantPluripotent Stem CellsHumansGene EditingCRISPR-Cas SystemsCell LineInduced Pluripotent Stem CellsRetinal Ganglion CellsMitochondria

Stichwörter der Autor:innen

CRISPR-Cas9 editingOPA1 genedominant optic atrophyisogenic human pluripotent stem cell linesmitochondria

Substanzen

GTP PhosphohydrolasesOPA1 protein, human

Autor:innen und Institutionen

  • Jules Stein Eye Institute, Department of Ophthalmology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
  • Molecular Biology Institute, University of California, Los Angeles, CA 90095, USA.
  • Department of Molecular and Medical Pharmacology, Davide Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
  • Doheny Eye Center, Department of Ophthalmology, University of California, Los Angeles, CA 91103, USA.

ORCID-Profile: Xian-Jie Yang

Förderung

  • NEI NIH HHS
  • NIH HHS
  • National Institute of Health (NIH)
  • California Institute of Regenerative Medicine (CIRM)
  • Research to Prevent Blindness to the Department of Ophthalmology at University of California, Los Angeles

Zitieren

APA

Pohl, K. A., Zhang, X., Ji, J. J., Stiles, L., Sadun, A. A., & Yang, X. J. (2025). Derivation and Characterization of Isogenic OPA1 Mutant and Control Human Pluripotent Stem Cell Lines. Cells. https://doi.org/10.3390/cells14020137

Vancouver

Pohl KA, Zhang X, Ji JJ, Stiles L, Sadun AA, Yang XJ. Derivation and Characterization of Isogenic OPA1 Mutant and Control Human Pluripotent Stem Cell Lines. Cells. 2025. doi:10.3390/cells14020137

BibTeX
@article{Pohl2025,
  author = {Pohl, Katherine A and Zhang, Xiangmei and Ji, Johnny Jeonghyun and Stiles, Linsey and Sadun, Alfredo A and Yang, Xian-Jie},
  title = {Derivation and Characterization of Isogenic OPA1 Mutant and Control Human Pluripotent Stem Cell Lines},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14020137}
}
Kostenlos starten →